Chart: Biotech Stocks - Revenue Per Employee
-
Font Size:
Rob Zenilman submits: Annual gross revenue per employee in the Biotech sector for the most recently reported fiscal year ranged from $1,067,578.90 (GILD) down to $117.30 (TELK), with a median value of $285,206.40
Data in table version -- click on a ticker for opinion and analysis of the company:
| FY | Revenue | ||||
|---|---|---|---|---|---|
| FY | Revenue | # of | Per Employee | ||
| Ticker | Company | Ending | ($mm) | Employees | ($000) |
| AFFX | Affymetrix Inc. | 12/31/05 | $367.60 | 1,101 | $333.88
|
| ALXN | Alexion Pharmaceutic | 12/31/05 | $1.21 | 241 | $5.00
|
| AMGN | Amgen Inc. | 12/31/05 | $12,430.00 | 16,450 | $755.62
|
| AMLN | Amylin Pharmaceutica | 12/31/05 | $140.47 | 1,150 | $122.15
|
| BIIB | Biogen Idec Inc. | 12/31/05 | $2,422.50 | 3,340 | $725.30
|
| BMRN | BioMarin Pharmaceuti | 12/31/05 | $25.67 | 314 | $81.75
|
| BSTE | Biosite Incorporated | 12/31/05 | $287.70 | 1,003 | $286.84
|
| CELG | Celgene Corporation | 12/31/05 | $536.94 | 944 | $568.79
|
| DNA | Genentech Inc. | 12/31/05 | $6,633.37 | 9,500 | $698.25
|
| ELN | Elan Corp. plc | 12/31/05 | $490.30 | 1,729 | $283.57
|
| GILD | Gilead Sciences Inc. | 12/31/05 | $2,028.40 | 1,900 | $1,067.58
|
| GPRO | Gen-Probe Inc. | 12/31/05 | $305.97 | 866 | $353.31
|
| IMCL | Imclone Systems Inc. | 12/31/05 | $383.67 | 991 | $387.16
|
| INCY | Incyte Corp. | 12/31/05 | $7.85 | 177 | $44.33
|
| ISTA | ISTA Pharmaceuticals | 12/31/05 | $10.66 | 161 | $66.21
|
| KOSP | KOS Pharmaceuticals | 12/31/05 | $751.70 | 1,361 | $552.31
|
| MEDI | MedImmune Inc. | 12/31/05 | $1,243.90 | 2,059 | $604.13
|
| NABI | Nabi Biopharmaceutic | 12/31/05 | $108.06 | 776 | $139.25
|
| NBIX | Neurocrine Bioscienc | 12/31/05 | $123.89 | 576 | $215.09
|
| ONXX | Onyx Pharmaceuticals | 12/31/05 | $1.00 | 100 | $10.00
|
| PGNX | Progenics Pharmaceut | 12/31/05 | $9.49 | 149 | $63.66
|
| PHRM | Pharmion Corp. | 12/31/05 | $221.24 | 328 | $674.52
|
| TELK | Telik Inc. | 12/31/05 | $0.02 | 162 | $0.12
|
| VRTX | Vertex Pharmaceutica | 12/31/05 | $160.89 | 810 | $198.63 |
Data: CapitalIQ
Related:
- Most recent opinion and analysis of Biotech stocks
- Full transcripts of recent conference calls in the Biotech sector
- Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Loading...
Symbols:
-
Editor's Picks
-
Most Popular
- iShares MSCI Mexico: Surprising Strength South of the Border
- A Fed Rate Hike Won't Solve the Current Crisis
- Understanding Metastorm's IPO as an Investment Opportunity
- Mr. Cuomo, ARS Investors Don't Need a Spitzeresque Settlement
- A Long Housing Boom Won't Yield to a Brief Recovery
- Why Congress Blames Index Speculators
- Full list of Editor's Picks »
- Three Stocks To Be Held To Infinity and Beyond »
- As WaMu, Wachovia Ready Earnings, Comparisons to Wells, USB Are Telling »
- Wall Street Breakfast: Must-Know News »
- Steve Jobs' Health: A Red Herring »
- Financials: How - And When - We Reached the Bottom »
- Four Long-Term Winners Selling at Deep Discounts »
- Apple F3Q08 (Qtr End 6/28/08) Earnings Call Transcript »
- Earnings Preview: Washington Mutual »
- Crazy Dividends »
- The Agriculture Boom Goes Bust »
- Apple's a Buy Under $150 »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Auto Retailers Ability to Pay Debt - What It Means
- Three Conservative Growth Industrial Picks: Adminstaff, Carlisle Companies and Illinois Tool Works
- Wait for August FFIEC Call Reports Before Taking a Long Position in Banks
- Now's the Time to Buy Something
- 3Com Corp.: Undervalued by Half
- Wachovia CEO's Insider Buying Is Another Indication of a Bottom
- Consumer Staple Stocks Are Not Always Safe Haven Investments
- The Long Case for Abbott Laboratories
- AT&T Stays Ahead of the Curve in a Dynamic Industry
- Dollar Back? - Fast Money Recap (7/23/08)
- Full list of Long Ideas »
- Is the Gold Uptrend Over?
- Response to Raymond James' Q3 Conference Call
- eBay is a Not Com - Cramer's Lightning Round (7/23/08)
- Get True Religion - Cramer's Lightning Round (7/22/08)
- Principal Financial Group Vulnerable to Commercial Real Estate Softening?
- Increases in Shorting, Only for Some
- Is a Ban on Short Financial ETFs on the Horizon?
- Is There a More Efficient Shorting Tactic?
- Short Oil as a Long Investment
- Ford's Financial Services Business About to Enter the Red
- Full list of Short Ideas »
- eBay is a Not Com - Cramer's Lightning Round (7/23/08)
- Buy Costco, Get Sirius - Cramer's Stop Trading! (7/23/08)
- Soup Target; Cramer's Mad Money (7/22/08)
- Get True Religion - Cramer's Lightning Round (7/22/08)
- Copper Down Low - Cramer's Stop Trading! (7/22/08)
- Banks Hit Bottom – Cramer’s Mad Money (7/21/08)
- Ends In X - Cramer's Stop Trading! (7/21/08)
- Great American Companies – Cramer’s Lightning Round (7/21/08)
- Market Rotation Bolsters Financials - Fast Money Recap (7/18/08)
- For Everything, Wind - Stop Trading! (7/17/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email


